These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 24030118)

  • 1. Increased PAC-1 expression among patients with multiple myeloma on concurrent thalidomide and warfarin.
    Abdullah WZ; Roshan TM; Hussin A; Zain WS; Abdullah D
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):893-5. PubMed ID: 24030118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation.
    Ito H; Miyakoda G; Mori T
    Platelets; 2004 Aug; 15(5):293-301. PubMed ID: 15370100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
    Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
    J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myeloma.
    Galli M; Elice F; Crippa C; Comotti B; Rodeghiero F; Barbui T
    Haematologica; 2004 Sep; 89(9):1141-2. PubMed ID: 15377478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry.
    Tomer A
    J Biol Regul Homeost Agents; 2004; 18(2):172-7. PubMed ID: 15471223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective cohort study of venous thromboembolism(VTE) in 1035 Japanese myeloma patients treated with thalidomide; lower incidence without statistically significant association between specific risk factors and development of VTE and effects of thromboprophylaxis with aspirin and warfarin.
    Kato A; Takano H; Ichikawa A; Koshino M; Igarashi A; Hattori K; Nagata K
    Thromb Res; 2013 Feb; 131(2):140-4. PubMed ID: 23232090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboprophylaxis prescribing and thrombotic event rates in multiple myeloma patients treated with lenalidomide or thalidomide at a specialist cancer hospital.
    Alexander M; Teoh KC; Lingaratnam S; Kirsa S; Mellor JD
    Asia Pac J Clin Oncol; 2013 Jun; 9(2):169-75. PubMed ID: 22998589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion.
    Rossi F; Rossi E; Pareti FI; Colli S; Tremoli E; Gallo L
    Haematologica; 2001 Feb; 86(2):192-8. PubMed ID: 11224490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
    Gawaz M; Ruf A; Neumann FJ; Pogátsa-Murray G; Dickfeld T; Zohlnhöfer D; Schömig A
    Thromb Haemost; 1998 Dec; 80(6):994-1001. PubMed ID: 9869173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida albicans and its metabolite gliotoxin inhibit platelet function via interaction with thiols.
    Bertling A; Niemann S; Uekötter A; Fegeler W; Lass-Flörl C; von Eiff C; Kehrel BE
    Thromb Haemost; 2010 Aug; 104(2):270-8. PubMed ID: 20431851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
    Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
    Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma.
    Baz R; Li L; Kottke-Marchant K; Srkalovic G; McGowan B; Yiannaki E; Karam MA; Faiman B; Jawde RA; Andresen S; Zeldis J; Hussein MA
    Mayo Clin Proc; 2005 Dec; 80(12):1568-74. PubMed ID: 16342649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicolor flow cytometry for evaluation of platelet surface antigens and activation markers.
    van Velzen JF; Laros-van Gorkom BA; Pop GA; van Heerde WL
    Thromb Res; 2012 Jul; 130(1):92-8. PubMed ID: 22424855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
    Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
    Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical platelet activation was not observed on dissociation of abciximab from GpIIb-IIIa complexes.
    Ndoko S; Poujol C; Combrié R; Nurden A; Nurden P
    Thromb Haemost; 2002 Feb; 87(2):317-22. PubMed ID: 11858493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation.
    Merten M; Beythien C; Gutensohn K; Kühnl P; Meinertz T; Thiagarajan P
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):258-63. PubMed ID: 15528476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelets enhance lymphocyte adhesion and infiltration into arterial thrombus.
    Hu H; Zhu L; Huang Z; Ji Q; Chatterjee M; Zhang W; Li N
    Thromb Haemost; 2010 Dec; 104(6):1184-92. PubMed ID: 20838746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
    Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
    Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets.
    McKenzie ME; Malinin AI; Bell CR; Dzhanashvili A; Horowitz ED; Oshrine BR; Atar D; Serebruany VL
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):249-53. PubMed ID: 12695747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two platelet activation markers using flow cytometry after in vitro shear stress exposure of whole human blood.
    Lu Q; Malinauskas RA
    Artif Organs; 2011 Feb; 35(2):137-44. PubMed ID: 20946295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.